• Return to Headlines

Relatively High EBITDA Growth Detected in Shares of Neogenomics Inc in the Life Sciences Tools & Services Industry (NEO, PRAH, BIO, PKI, QGEN)

By Shiri Gupta

Below are the three companies in the Life Sciences Tools & Services industry with the highest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.

Neogenomics Inc ranks highest with a EBITDA growth of 84.3%. Following is Pra Health Scien with a EBITDA growth of 75.2%. Bio-Rad Labs-A ranks third highest with a EBITDA growth of 54.5%.

Perkinelmer Inc follows with a EBITDA growth of 47.7%, and Qiagen Nv rounds out the top five with a EBITDA growth of 45.9%.

SmarTrend is tracking the current trend status for Neogenomics Inc and will alert subscribers who have NEO in their portfolio or watchlist when shares have changed trend direction.

Keywords: highest ebitda growth neogenomics inc pra health scien bio-rad labs-a perkinelmer inc qiagen nv

Ticker(s): NEO PRAH BIO PKI QGEN